Hm Payson & CO Age X Therapeutics, Inc. Transaction History

Hm Payson & CO

  • $5.81 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Jul 01, 2020
SELL
$0.78 - $1.95 $206 - $516
-265 Closed
0 $0
Q2 2019

Aug 15, 2019
BUY
$2.58 - $4.92 $683 - $1,303
265 New
265 $1,000

Others Institutions Holding AGE

# of Institutions
1
Shares Held
1K
Call Options Held
0
Put Options Held
0
View Full List

About AgeX Therapeutics, Inc.

AGE Quotes by TradingView
  • Ticker AGE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,945,100
  • Description
  • AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-rel...
More about AGE
Track This Portfolio

Track Hm Payson & CO Portfolio

Follow Hm Payson & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

News

Stay updated on Hm Payson & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email